Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer

Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer / Viale, G., Regan, M.m., Dell'Orto, P., Mastropasqua, M.g., Rasmussen, B.b., Macgrogan, G., Braye, S., Orosz, Z., Giobbie-Hurder, A., Neven, P., Knox, F., Oehlschlegel, C., Thuerlimann, B., Coates, A.s., Goldhirsch, A.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 69:24(2009), pp. 504S-504S.